Dandio, Ricky G.
HRN: 22-47-20 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/09/2023
01/16/2023
IV
4.5g
Q6
Sepsis Sec To CAP HR Vs PTB
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes